Blog

GSK’s $50m Acquisition Revolutionizes Oligonucleotide Drug Development
📢 GSK acquires Elsie Biotechnologies in a $50m deal to enhance its drug platform and develop treatments for difficult-to-treat diseases. 🧬👥🚀

WuXi Biologics Supercharges Manufacturing with 5000L Bioreactors!
⚡ WuXi Biologics upgrades manufacturing capability with installation of three 5,000L single-use bioreactors! 🏭✨🔝

Revolutionary Genomic Tech Promises Cheaper Animal Vaccines
📅 June 3, 2024: High costs and technical difficulties limit animal vaccine development. 💉 New QTL technology offers affordable and effective vaccines. 🔬🚀

Vetter’s Explosive Expansion: More Jobs Bigger Capacity!
📢 Vetter, the CDMO, is expanding in the U.S. and Germany to meet growing demand in the injectable industry. 💼

Entos Pharmaceuticals Expands Manufacturing Powerhouse
📢 Entos Pharmaceuticals opens GMP facility in Carlsbad, CA to support studies and trials, advancing pipeline of 20 programs. 🔬💰🌎

Revolutionizing Cell Therapy: Likarda and Cold Chain Technologies Join Forces
🚚🧪 Likarda and Cold Chain Technologies join forces to revolutionize cell therapy manufacturing with advanced logistics solutions.

Boosting mAb Manufacturing: Scottish Study Reveals Best Separation Systems
🔍 Scottish researchers evaluated 44 elution strategies, with seven-stage ultrafiltration systems performing the best. 💡 High concentration yields and cost savings can be achieved with integrated ultrafilters.

Revolutionizing Data Integration in Bioprocessing: How AI and Algorithms are Transforming Analysis
📰 Improving Data Integration: Challenges in bioprocessing include fragmented data, but tools like GPT-4 and StabMap help analyze efficiently. 🧬💻🔬

Massive Funding Boost for Revolutionary Cancer Treatment
🔬💰 Isotope Technologies Munich SE secures €188m in equity funding for radiopharma pipeline and launch of ITM-11. 🚀💉🔬

Biotech Breakthrough! Quantro Therapeutics Cashes In
📢 Austrian biotech company QUANTRO Therapeutics receives milestone payment from Boehringer Ingelheim for successful collaboration. 💰🔬💼





